|
|
|
|
| LEADER |
01720namaa2200481ui 4500 |
| 001 |
003027468 |
| 005 |
20221228153937.0 |
| 003 |
DE-2553 |
| 006 |
m o d |
| 007 |
cr|mn|---annan |
| 008 |
20210211s2015 xx |||||o ||| 0|eng d |
| 020 |
|
|
|a 978-2-88919-535-0
|
| 020 |
|
|
|a 9782889195350
|
| 040 |
|
|
|a oapen
|c oapen
|b eng
|d DE-2553
|e rda
|
| 024 |
7 |
|
|a 10.3389/978-2-88919-535-0
|c doi
|
| 041 |
0 |
|
|a eng
|
| 042 |
|
|
|a dc
|
| 100 |
1 |
|
|a Ludovic Martin
|e author
|
| 245 |
1 |
0 |
|a 2015: Which new directions for Alzheimer's disease?
|
| 264 |
|
|
|b Frontiers Media SA,
|c 2015.
|
| 300 |
|
|
|a 1 online resource (122 pages).
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Frontiers Research Topics
|
| 506 |
0 |
|
|a Open Access
|2 star
|f Unrestricted online access
|
| 540 |
|
|
|a Creative Commons
|f https://creativecommons.org/licenses/by/4.0/
|2 cc
|4 https://creativecommons.org/licenses/by/4.0/
|
| 546 |
|
|
|a English
|
| 653 |
|
|
|a kinase inhibitors
|
| 653 |
|
|
|a Therapeutics
|
| 653 |
|
|
|a tau
|
| 653 |
|
|
|a TREM2
|
| 653 |
|
|
|a Alzheimers disease
|
| 653 |
|
|
|a microbiome
|
| 653 |
|
|
|a Aβ peptides
|
| 856 |
4 |
0 |
|a www.oapen.org
|u http://journal.frontiersin.org/researchtopic/1283/2014-what-new-directions-for-alzheimers-disease
|7 0
|z DOAB: download the publication
|
| 856 |
4 |
0 |
|a www.oapen.org
|u https://directory.doabooks.org/handle/20.500.12854/39880
|7 0
|z DOAB: description of the publication
|
| 590 |
|
|
|a Online publication
|
| 590 |
|
|
|a ebookoa1222
|
| 590 |
|
|
|a doab
|
| 942 |
|
|
|2 z
|c EB
|
| 999 |
|
|
|c 3027468
|d 1431223
|
| 952 |
|
|
|0 0
|1 0
|2 z
|4 0
|6 ONLINE
|7 1
|9 973107
|R 2022-12-28 14:39:37
|a DAIG
|b DAIG
|l 0
|o Online
|r 2022-12-28
|y EB
|
